Details of the Drug-Related molecule(s) Interaction Atlas

General Information of Drug (ID: DMP05GL)

Drug Name
LYC-30937 Drug Info
Indication
Disease Entry ICD 11 Status REF
Plaque psoriasis EA90.0 Phase 2 [1]
Ulcerative colitis DD71 Phase 2 [2]
Cross-matching ID
TTD Drug ID
DMP05GL

Molecule-Related Drug Atlas

Molecule-Related Drug Atlas
Molecule Type:
DTT
Drug Status:
Discontinued Drug(s)
Download the Complete Related Drug List
Drug(s) Targeting ATP phosphatase (ATPase)
Drug Name Drug ID Indication ICD 11 Highest Status REF
BY-1949 DM8ZFS3 Cognitive impairment 6D71 Discontinued in Phase 2 [3]
FR-76830 DM7WGXS Angina pectoris BA40 Terminated [4]

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas
Download the Complete Interaction Atlas for Visualization in Cytoscape

Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
ATP phosphatase (ATPase) TT5WKM8 NOUNIPROTAC Modulator [2]

References

1 Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)
2 Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)
3 An activation of synaptosomal Na+,K(+)-ATPase by a novel dibenzoxazepine derivative (BY-1949) in the rat brain: its functional role in the neurotransmitter uptake systems. J Neurochem. 1992 Jan;58(1):362-8.
4 On the mode of cardioprotection produced by a new bradycardic agent, FR 76830, during ischaemia and after reperfusion in the isolated perfused rat heart: a 31P-NMR study. Cardiovasc Res. 1990 Dec;24(12):1008-12.